Vertex Pharma (VRTX) Misses Q3 EPS by 2c; Plans to Commence Two CF-Focused Phase 2s
Go back to Vertex Pharma (VRTX) Misses Q3 EPS by 2c; Plans to Commence Two CF-Focused Phase 2s| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 510.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $510.72 | 52 Week High | $134.71 | |||
| Open | $510.72 | 52 Week Low | $73.31 | |||
| Day High | $510.72 | P/E | N/A | |||
| Day Low | $510.72 | EPS | $-1.98 | |||
| Volume | 345 | |||||
